Skip to main content
SpringerLink
Log in

Infliximab: elevated risk of psychiatric adverse events

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Thillard E-M, et al. Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database. Frontiers in Pharmacology : 22 Apr 2020. Available from: URL: https://doi.org/10.3389/fphar.2020.00513

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Infliximab: elevated risk of psychiatric adverse events. Reactions Weekly 1805, 9 (2020). https://doi.org/10.1007/s40278-020-78719-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-78719-z

Search

Navigation